The ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD) plays a crucial role in improving the diagnosis, treatment, prevention, and control of infectious diseases by harnessing the power of molecular and genomic techniques. Committed to pioneer innovation, research, education, and policy development in clinical microbiology in diagnostics, ESGMD aims to:
The added value of metagenomic next-generation sequencing in central nervous system infections: a systematic review of case reports.
Birkeland KW, Mostert L, Claas ECJ, Aamot HV, Demuyser T. Infection. 2025 Jun;53(3):831-849
Towards unified reporting of genome sequencing results in clinical microbiology.
Mutschler E, Roloff T, Neves A, Vangstein Aamot H, Rodriguez-Sanchez B, Ramirez M, Rossen J, Couto N, Novais Â, Howden BP, Brisse S, Reuter S, Nolte O, Egli A, Seth-Smith HMB; ESCMID Study Group for Epidemiological Markers (ESGEM), and ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD). PeerJ. 2024 Aug 8;12:e17673
Antimicrobial susceptibility prediction from genomes: a dream come true?
Werner G, Aamot HV, Couto N. Trends Microbiol. 2024 Apr;32(4):317-318
Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains.
Cuénod A, Aerni M, Bagutti C, Bayraktar C, Boz ES, Carneiro CB 6, Casanova C, Coste AT, Damborg P, van Dam DW, Demirci M, Drevinek P, Dubuis O, Fernandez J, Greub G, Hrabak J, Yiğitler GH, Hurych J, Jensen TG, Jost G, Kampinga GA, Kittl S, Lammens C, Lang C, Lienhard R, Logan J, Maffioli C, Mareković I, Marschal M, Moran-Gilad J,Nolte O, Oberle M, Pedersen M, Pflüger V, Pranghofer S, Reichl J, Rentenaar RJ, Riat AR, Rodríguez-Sánchez B, Schilt C, Schlotterbeck AK, Schrenzel J, Troib S, Willems E, Wootton M, Ziegler D, Egli A. Clincal Microbiology and Infection 2023;29(2):190–199.
05
May 25
If you have questions or comments for our study group, we warmly invite you to contact us!
